New Blood Test Detects Lung Cancer Up to Five Years Before Symptoms Appear

Hemoglobin A1c, commonly known as HbA1c or glycated hemoglobin, is a laboratory test that measures the average blood sugar levels over the past two to three months. This test provides valuable information about long-term glucose control and is widely used in the diagnosis and management of diabetes. Unlike regular blood glucose tests that show sugar levels at a single point in time, HbA1c reflects how well blood sugar has been controlled over an extended period. The test measures the percentage of hemoglobin proteins in red blood cells that have glucose attached to them. Since red blood cells live for approximately three months, the HbA1c test gives healthcare providers a comprehensive picture of average blood sugar levels during that timeframe.

The HbA1c test is primarily used to diagnose prediabetes and diabetes, as well as to monitor how well people with diabetes are managing their condition. For diagnosis, an HbA1c level below 5.7 percent is considered normal. A level between 5.7 and 6.4 percent indicates prediabetes, which means blood sugar levels are higher than normal but not yet high enough to be classified as diabetes. An HbA1c level of 6.5 percent or higher on two separate tests indicates diabetes. For people already diagnosed with diabetes, the test helps determine whether current treatment plans are effective or need adjustment. Most diabetes treatment guidelines recommend that individuals with diabetes aim for an HbA1c level below 7 percent, though target levels may vary based on individual circumstances and should be discussed with a healthcare provider.

The HbA1c test offers several advantages over traditional glucose testing methods. It does not require fasting before the blood draw, making it more convenient for patients. The test is not affected by short-term changes in blood sugar levels caused by stress, illness, or recent meals, providing a more stable measurement of overall glucose control. Additionally, a single HbA1c test can replace multiple fasting glucose tests, reducing the number of clinic visits needed. However, certain conditions can affect the accuracy of HbA1c results, including anemia, recent blood transfusions, certain hemoglobin variants, kidney disease, and liver disease. In such cases, healthcare providers may use alternative testing methods or interpret results with additional clinical information.

Regular HbA1c testing is recommended for people with diabetes, typically every three to six months depending on how well their condition is controlled and whether treatment plans have recently changed. For individuals with prediabetes, periodic testing helps monitor progression and evaluate the effectiveness of lifestyle modifications aimed at preventing diabetes. Understanding HbA1c results empowers patients to work more effectively with their healthcare team to manage blood sugar levels through diet, exercise, medication, or a combination of these approaches. Early detection and consistent monitoring through HbA1c testing play crucial roles in preventing or delaying diabetes-related complications such as heart disease, kidney damage, nerve problems, and vision loss.